A Zantac lawsuit is a legal claim filed by people who developed cancer after taking Zantac and ranitidine tainted with NDMA. Zantac lawsuits seek compensation from the drug makers for cancers of the bladder, stomach, esophagus, liver, and pancreas that may have been caused by NDMA exposure.
Cancers that qualify for Zantac lawsuits include:
People must meet several prerequisites, according to Zantac lawyers, in order to be eligible for a lawsuit: documented Zantac use, a cancer diagnosis, and a link between the disease and Zantac. Lawyers are only considering claims from persons who used the brand-name Zantac, and generic ranitidine is no longer covered.
Bladder, gastric/stomach, esophageal, liver and pancreatic
Sanofi-Aventis U.S. LLC, Sanofi US Services Inc., Chattem, Inc., Boehringer Ingelheim, Pfizer and GlaxoSmithKline
Initial stages, no trials scheduled
511 SE 5th Ave Suite 904 Fort Lauderdale, FL 33301 (T) 954-562-9714 (F) 954-765-6382
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.